top of page

Product Of Nature Doctrine & CRISPR- Cas9: Ethical Issues




Rushmitha, B.A. LL.B., (Hons)., LLM, (Department of Intellectual Property Law) TNDALU, School of Excellence in Law, The Tamilnadu Dr. Ambedkar Law University (School of Excellence in Law)


ABSTRACT


The product of nature doctrine plays a crucial role in determining the patentability of genetic materials and biotechnological innovations, particularly in the context of advanced gene-editing technologies like CRISPR-Cas9. This doctrine asserts that natural phenomena, including naturally occurring genes and genetic sequences, cannot be patented, as they are products of nature. However, the emergence of CRISPR technology has blurred the lines between natural and synthetic, leading to complex legal and ethical challenges surrounding the patenting of isolated DNA sequences and genetically modified organisms. This abstract explores the implications of the product of nature doctrine as it pertains to CRISPR-Cas9, emphasizing the need for clarity in patent laws to accommodate innovations that arise from significant human intervention. Furthermore, ethical issues, including concerns over unintended genetic consequences, social inequality, and the potential for eugenics, are examined. The ethical considerations surrounding the use of CRISPR for germline editing raise questions about individual autonomy, consent, and the long-term impacts on future generations. As CRISPR technology continues to advance, it is imperative to navigate the intersection of legal frameworks and ethical standards thoughtfully. Establishing comprehensive guidelines that address both patentability and ethical implications will be essential for fostering responsible innovation while safeguarding public health and social equity. This exploration underscores the urgency of engaging diverse stakeholders in dialogue and developing frameworks that balance scientific progress with ethical responsibility.


Keywords: Genetic Materials, Biotechnological Innovations, CRISPR- Cas9 Patents, Human Intervention in Biotechnology, Genetic Engineering Innovation.

Comentarios


Indian Journal of Law and Legal Research

Abbreviation: IJLLR

ISSN: 2582-8878

Website: www.ijllr.com

Accessibility: Open Access

License: Creative Commons 4.0

Submit Manuscript: Click here

Open Access Logo

Licensing:

​All research articles published in The Indian Journal of Law and Legal Research are fully open access. i.e. immediately freely available to read, download and share. Articles are published under the terms of a Creative Commons license which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Disclaimer:

The opinions expressed in this publication are those of the authors. They do not purport to reflect the opinions or views of the IJLLR or its members. The designations employed in this publication and the presentation of material therein do not imply the expression of any opinion whatsoever on the part of the IJLLR.

bottom of page